Convening of annual general meeting of Totalkredit A/S

Udgivet den 07-03-2024  |  kl. 09:00  |  

To Nasdaq Copenhagen

Convening of annual general meeting of Totalkredit A/S

Totalkredit A/S will hold its annual general meeting on Thursday, 21 March 2024 at 10:00 at the Company's offices at Kalvebod Brygge 1-3, DK-1560 Copenhagen V.

-o0o-

Agenda:

The Directors' report on the Company's activities in the past year.

Presentation of the Annual Report 2023 for approval and resolution on the discharge of the Board of Directors and Executive Board.

Proposal for the appropriation of profit according to the approved Annual Report.

Election of members of the Board of Directors.

Appointment of auditors.

Remuneration matters, including the Remuneration Policy and remuneration report for approval.

Any other business.

The agenda of the Company's general meeting, the updated Remuneration Policy, the remuneration report as well as the Company's Annual Report will be available for inspection by the shareholders at the Company's address prior to the general meeting.

Item 4 on the agenda proposes re-election of Michael Rasmussen, David Hellemann and Anders Jensen and election of Pernille Sindby for the Board of Directors. The CV of Pernille Sindby is enclosed as Appendix 1.

As item 5 on the agenda the Board of Directors proposes re-appointment of EY Godkendt Revisionspartnerselskab as auditors of the Company.

Admittance to the general meeting is subject to collection of an admission card at least three days prior to the general meeting.

It should be noted that Nykredit Realkredit A/S owns all the shares of the Company.

Copenhagen, 7 March 2024

Totalkredit A/S
Board of Directors

Contact
Questions may be addressed to Press Relations, tel +45 60 56 32 30.

Attachments

Indkaldelse til OGF 2024 - Totalkredit_uk CV - Pernille Sindby_uk

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

17:49 Europa/lukning: Danske fedmeaktier blødte og trak Europa i rødt
17:19 Fredagens obligationer: Renter faldt efter amerikanske inflationstal
17:18 Novo banket i bund efter skuffende data - aktionærerne tabte omkring 690 mia. kr.
17:06 Fredagens aktier: Øretæver til Novo Nordisk og Zealand Pharma giver solid C25-nedtur
15:46 USA/åbning: Eli Lilly vinder på Novos kollaps mens inflationsdata skærer lidt af dykket
15:17 Jeudan har milliarder klar til opkøb: "Øget optimisme kan give flere transaktioner i 2025"
15:15 Novo/Jyske Bank: Kursreaktion virker som overreaktion
14:29 USA/tendens: Eli Lilly vinder på Novos kollaps mens frygt for nedlukning varsler rød start
13:33 Korr: Udsalg af Novo-aktier presser kronen
13:24 Udsalg af Novo-aktier presser kronen
12:29 Sydbank-analytiker: Voldsomt kursfald afspejler skuffelsen over Cagrisema-data
12:25 Europa/aktier: Danske fedmeaktier bløder og trækker Europa i rødt
12:22 Novo smadres på børsen efter skuffende fedmestudie - aktien taber 770 mia. kr.
12:11 Novos styrtdyk trækker C25-indekset ned i sit fjerdestørste fald nogensinde
12:09 Gubra og Zealand Pharma trækkes med ned af negativt nyt til Novo Nordisk
12:05 Novo lever ikke op til egne forventninger i vigtigt studie - aktien mister 900 mia kr -NY2
11:56 Novo lever ikke op til egne forventninger i kursfølsomt studie - aktien mister 700 mia kr
11:48 Aktier/middag: Zealand Pharma bankes tocifret ned efter FDA-afvisning og trækker C25 ned
11:28 Obligationer/middag: Små renteudsving før inflationsnyt fra USA
10:49 Jefferies ser kurslussing til Zealand Pharma som købsmulighed